The biggest and best of all MedTech trade shows is back on, with fewer attendees but still of high quality. We were there.

It was lightly attended, but quality discussione ensued reflecting the state of the industry: “There are certain parts that are beginning to become scare. We are all dealing with the issue, finding alternate sources and substituting materials.” - MedTech CEO

NASS 2021 was held in Boston this week. Larry Barr was there from Middle Branch Partners.

Some consider trade shows to be a necessary evil — be seen or be gone. Others see them as a great tool in their marketing kit. They are a really a combination of both. As we re-enter a more customary world of MedTech tradeshows and events, it may be useful to look at why we attend them in the first place.

Middle Branch Partner’s Larry Barr was at Medical Packaging and Pack Expo this week. Held in Las Vegas, it was decently attended and good discussions ensured.

The BIOMEDevice show was in Boston this week and was lightly attended. Nevertheless Middle Branch Partners was there and we had some highly quality discssions for our clients.

Mike Evers of Orthoworld discusses how the orthopedic market outperformed expectations in the first half of 2021, given gaps in vaccine coverage and the surging delta variant.

Content republished with permission from ORTHOWORLD® Inc.

Middle Branch partners advised on these two providers of medical coating tech.

AAOS 2021 is underway in San Diego. This year, beacuse of Covid, it is a very different show. Take a look.

Back in the saddle again. MD&M West is back with lighter-than-usual attendance but with a productive program.

An interview with our partners Larry Barr, Göran Brorsson, and Chuck Weikel discussing the first half of 2021 in the MedTech M&A markets.

Mike Evers of Orthoworld discusses the state of Orthopedic markets and M&A in 2Q21. As we near 2Q earnings, we're watching for a barometer of the market's recovery, momentum in M&A, as well as the evolution toward digital.

Content republished with permission from ORTHOWORLD® Inc.

For years we have always thought the best technical reference for the MedTech metals industry is the Orthomaterials Pocketbook put out by our friends at Forécru. With contributions by leading companies across the industry, it has much detail about the processes used and details that even non-engineers can understand.

Panelists Laurence Barr, Founding Partner at Middle Branch Partners; David Anderson, Managing Director at Capital One Healthcare; Marie Lotto, Senior Director of M&A Integration at Hologic; and moderator Charles Weikel, Founding Partner at Middle Branch Partners had a great conversation about the state of MedTech M&A markets and finance during late-COVID. If you couldn't attend the webinar, or want to revisit portions of the conversation, you may now view the archived video on YouTube.

Middle Branch Partners and Capital One are pleased to present the first in a series of webinars on MedTech, banking, and the state of mergers and acquisitions in 2021 and beyond. Speakers include: Laurence Barr, Founding Partner at Middle Branch Partners; David Anderson, Managing Director at Capital One Healthcare; and Marie Lotto, Senior Director of M&A Integration at Hologic.

Our client is the owner of world class contract manufacturers that specialize in MedTech machining, surgical instruments and other associated devices, machinery and services. Capabilities include precision micro machining, engineering and prototyping, med device PCB fabrication and assembly. Of particular interest are filtration, micro maching and cabling & connection technologies.

Welcome to Tim Kelleher, Former President, Teleflex OEM who has joined Middle Branch Partner’s Board of Advisors. Under his leadership as President, the Teleflex Medical OEM business unit created three world class EPIC Medtec® Centers, completed a number of key acquisitions, and expanded its manufacturing and development footprint in seven locations, leading to a significant increase in the growth and profitability of the business.

Carolyn LaWell of Orthoworld offers this advice regarding medical device commercialization in emerging markets: consider new geographies early in your worldwide expansion based on ease of regulatory and reimbursement processes.

Content republished with permission from ORTHOWORLD® Inc.

Early earnings previews from companies reinforce Orthoworld’s belief that the orthopedic market will decline around -10% in 2020. Below they preview some positives from the fourth quarter and the most recent COVID and U.S. jobs data, as well as some early thoughts for 2021.

Content republished with permission from ORTHOWORLD® Inc.

Our client is a world class contract manufacturer that specializes in implants, surgical instruments and other associated devices and services. They are able to serve their customers world-wide due to their unique global footprint.